Authors


Joseph Friedman, RPh, MBA

Latest:

Should you establish a medical marijuana dispensary?

If your inner entrepreneur is hollering to get out, maybe you should go for it.



Peter A. Kreckel, RPh

Latest:

The Perils of Frivolous Lawsuits

Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.


Perry Cohen, PharmD, FAMCP

Latest:

It's Time for Pharmacists to Carve Out a New Role

Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.


Susan Egbert

Latest:

Patients and Herbal Supplements

Your patients are using herbal products, but do you know enough about them?


David Stanley, RPh

Latest:

Hold the phone

How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.


John Schieszer, MA

Latest:

Barriers Coming Down for Complex Generic Drug Products

This year may mark a dramatic difference in the development and approval of complex generic drug products.


Jeff Cineas, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Stephanie Trexler, PharmD Candidate

Latest:

Apalutimide for Prostate Cancer: What to Know

FDA approves apalutamide for castration-resistant prostate cancer.


Dustyn Williams, MD

Latest:

Diabetes Management and the Promise of Telemedicine

Could telemedicine be the answer to diabetes management problems?


Zoe Barry

Latest:

Fixing a Broken System with Technology

Technology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.


Paul Armentano

Latest:

Making the Case for Regulated Marijuana

Pharmacists urged to support controls to the marijuana market but oppose criminalization.


Anita Siu, PharmD, BCPPS

Latest:

Pediatric Patients Present Unique Challenges to Pharmacists

Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.


Gianna Casal, PharmD

Latest:

Betrixaban for Prophylaxis of Venous Thromboembolism

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 


Matthew Davis, PharmD

Latest:

Betrixaban for Prophylaxis of Venous Thromboembolism

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 


Deepak Thomas

Latest:

Four Things Pharmacists Need to Know About Specialty Pharmacy

How independent pharmacies can use specialty medications to increase profits and help their patients. 


David Pope, PharmD, CDE

Latest:

Let’s Do This! A Call to Action for Test to Treat in Pharmacy

President Biden’s recent State of the Union address included a pharmacy Test to Treat iniativie for COVID-19.


David Smith, RPh

Latest:

What Community Pharmacists Want-And How You Can Get It

NCPA found three things that pharmacists desperately want changed. Here’s how they’re going to do it.


James A Jorgenson, RPh, MS

Latest:

Pharmacists, It’s Time to Speak Up

Healthcare is at a dangerous place right now-but pharmacists can be the ones to help save it.


Tyree H. Kiser, Pharm D.

Latest:

Critical Care Board Certification Gains Momentum

If you’ve never thought about becoming certified, now is a great time to do it.


Chuck Green

Latest:

The Smart Technology That Will Change Diabetes Care

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 


John Lindsley, PharmD, BCPS-AQ Cardiology

Latest:

How Pharmacists Can Tackle the Leading Cause of Death

Interested in cardiology? Here’s why you should consider becoming extra training and certification.



Joseph L Lee PharmD, MPH Candidate 2019

Latest:

Why Pharmacists Need to Change Their Attitude

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.


Shyam Patel, PharmD

Latest:

New Drug Review: Spravato

Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo


Lindsey M. Childs-Kean, PharmD, MPH, BCPS

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Kevin Deemer, PharmD

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Carlos Madruga, PharmD

Latest:

Advances in Hepatitis C Treatment

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.


Allan Ginsberg, RPh, MHA, CMTM

Latest:

Why I Still Recommend the Pharmacist Profession

Pharmacy has changed a lot in the last 50 years-but a lot of that has been for the good of the profession and the public.


Jennifer Gershman, PharmD, CPh

Latest:

On Cystic Fibrosis Multidisciplinary Care Teams, Pharmacists Are Vital

Pharmacists are essential for managing complex CF regimens, monitoring their effectiveness, and improving adherence.

© 2024 MJH Life Sciences

All rights reserved.